8.Care Redesign Case: Kaiser Health System (Generic Prescribing)

MODULE 6 | Section 8 of 10

Care Redesign Case: Kaiser Health System (Generic Prescribing)

CARE REDESIGN CASE: KAISER PERMANENTE NORTHERN CALIFORNIA HYPERTENSION OUTCOMES

Kaiser Permanente Northern California (KPNC) is a not-for-profit, integrated health care delivery system that was founded in 1945 in Oakland, California. KPNC includes a health plan, hospital system, and a physician group practice.1 It is currently the second largest region (by number of members) of the national Kaiser Permanente group.

 

As of 2013, KPNC cared for more than 2.3 million adult members, with comprehensive inpatient and outpatient care provided through 21 hospitals, 45 medical facilities, and more than 7000 physicians.2

 

This case study focuses on a comprehensive program that KPNC launched in 2001 to improve hypertension outcomes across their patient population through a number of strategies, which included improving regular medication adherence.

 

In the late 1990s, fewer than half of Americans diagnosed with hypertension had controlled blood pressure (BP). KPNC recorded their rate of patients with controlled BP at 44% in 2001, when they developed a system-wide, multifaceted program for hypertension management.2,3

 

The program consisted of five key components:

1

DEVELOPING A HYPERTENSION REGISTRY

The group first identified all KPNC patients diagnosed with high BP and included them in a registry that captured their basic demographic information and allowed them to monitor and evaluate their progress. The registry grew over time from 350,000 to more than 650,000 in 2016.3

2

ESTABLISHING CLEAR EVIDENCE-BASED PROTOCOLS

KPNC created rigorous evidence-based guidelines for the entire system. “A critical characteristic of the hypertension guidelines has been a simplified drug treatment algorithm (protocol),” wrote Drs. Marc Jaffe and Joseph Young, who helped lead the KPNC research group.3 “Instead of listing several potential drug classes or several specific medications as potential options for each step in the protocol, a single specific drug with a recommended dose is advised in nearly all situations. This facilitates the use of fewer drugs, which can lead to improved familiarity, decreased practice variation, and simplification of teaching materials, resulting in increased efficiencies and potentially fewer medical errors.” This strategy captures some of the principles of conservative prescribing discussed earlier in this module. “Importantly, the guideline provides clear advice on how to initiate and escalate both doses and numbers of drugs to achieve blood pressure control but does so in a manner that is not prescriptive and enables clinicians to retain decision-making autonomy,” noted Drs. Abhinav Goyal and William Bornstein in an editorial for JAMA.4 The guidelines are updated every two years and are distributed through many forms throughout the organization.

3

SHARING BEST PRACTICES

The results of each medical center were regularly monitored and a central team identified the best performing centers. They contacted teams at those sites and sought to identify best practices, which were then shared with other medical centers throughout the network via training sessions, prepared lectures, email and other methods.

4

NO-COST FOLLOW-UP VISITS WITH MEDICAL ASSISTANTS

Beginning in 2007, KPNC offered patients medical assistant BP visits, usually scheduled 2 to 4 weeks following a BP medication adjustments. Patients did not need to pay a co-pay for these visits, so they were no-cost to patients. These visits could also be scheduled at flexible times. The medical assistant obtained the BP, and the primary care physician could then direct treatment intensification and follow-up care as needed.

5

SINGLE-PILL COMBINATION THERAPY

In 2005, KPNC incorporated a single generic pill that combined two common BP medications (Lisinopril-hydrochlorothiazide) into the evidence-based guidelines. Physicians and patients were educated about this option. The new treatment was less costly and easier to use than separate doses, improving patient adherence. From 2001 to 2009, the number of lisinopril-hydrochlorothiazide prescriptions increased from fewer than 20 to more than 23,000 per month.3

KEY ELEMENTS OF THE KAISER PERMANENTE NORTHERN CALIFORNIA HYPERTENSION PROGRAM

ELEMENT
DESCRIPTION

 

Hypertension registry
Clinic level performance feedback
Treatment algorithm
Medical assistant visits for blood pressure measurement
Single-pill combination therapy
Validated and comprehensive
Facilitates operational and system-level change, transparent, and widely visible
Based on evidence-based guidelines, simple and implementable
Appropriate use of ancillary staff skills and reduced barriers to patients
Increased efficiency and increased adherence
Source: Jaffe MG, Young JD. The Kaiser Permanente Northern California Story: Improving Hypertension Control From 44% to 90% in 13 Years (2000 to 2013). J Clin Hypertens Greenwich conn. 2016;18(4):260-261.

RESULTS

The results of this systemic approach to improving hypertension treatment were impressive. Over the first 8 years (from 2001 to 2009) the percentage of patients with hypertension who achieved BP control increased from 44% to 80%.2 This was better than national trends in BP control. By 2013, KPNC achieved 90% BP control.3

 

“In the late 1990s, when uncontrolled blood pressure was the norm, BP control rates of 90% seemed unimaginable,” wrote Drs. Marc Jaffe and Joseph Young.3

 

Over the same time period, the rate of heart attacks fell 24% and death from stroke declined by 42%.3

 

“This was and continues to be a team effort – with thousands of physicians, pharmacists, nurses, managers, data analysts, and others who work tirelessly to help our patients maintain healthy BP levels. How far we’ve come in the past 14 years!” wrote Drs. Jaffe and Young in a 2016 editorial.3

M6s8p4
Figure caption: National Committee for Quality Assurance (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS) Hypertension Control RatesA, NCQA HEDIS hypertension control rates comparing Kaiser Permanente Northern California (KPNC), national, and California, 2001-2009. B, NCQA HEDIS hypertension control rates within KPNC vs KPNC internal hypertension registry control rates, 2001-2009. Error bars indicate 95% CIs for the KPNC NCQA HEDIS hypertension rates; 95% CIs for the KPNC internal hypertension registry control rates are not shown, because they are extremely small (<0.3%). From: Improved Blood Pressure Control Associated With a Large-Scale Hypertension Program2

ADDITIONAL RESOURCE

Click the image to watch “Improved Blood Pressure Control Associated with a Large-Scale Hypertension Program” (Will open in new tab).

REFERENCES

  1. 1- Northern California Fast Facts. Kaiser Permanente Share. Accessed February 28, 2018.
  2.  
  3. 2- Jaffe MG, Lee GA, Young JD, Sidney S, Go AS. Improved Blood Pressure Control Associated With a Large-Scale Hypertension ProgramJAMA. 2013;310(7):699-705. doi:10.1001/jama.2013.108769

 

  1. 3- Jaffe MG, Young JD. The Kaiser Permanente Northern California Story: Improving Hypertension Control From 44% to 90% in 13 Years (2000 to 2013)J Clin Hypertens Greenwich Conn. 2016;18(4):260-261. doi:10.1111/jch.12803

 

  1. 4- Goyal A, Bornstein WA. Health System–Wide Quality Programs to Improve Blood Pressure ControlJAMA 2013;310(7):695-696. doi:10.1001/jama.2013.108776

Leave a Comment